Quick Details
- Processing Time:3 days
- Port:shanghai
- Supply Ability: 100 Boxes Per Day
- Brand Name:Chinqesen Biotechnology
Semaglutide is aIt is an
anti-diabetic drug for type 2 diabetes and a weight-loss drug for long-term weight management developed by Novo Nordisk in 2012
Semaglutide has been
modified with short-chain PEG, which greatly enhances its hydrophilicity. PEG modification can not only bind tightly to albumin and ignore the DPP-4 enzyme promotion site, but also reduce renal
excretion, extend biological half-life, and achieve long circulation effects.
Product Name
Semaglutide
Appearance
powder
CAS NO
910463-68-2
Molecular Formula
C187H291N45O59
Specification
5mg,10mg 15mg /vial,10vials/box
